UA110280C2 - Micellar composition for delivery of cancer drugs - Google Patents

Micellar composition for delivery of cancer drugs

Info

Publication number
UA110280C2
UA110280C2 UAA201405945A UAA201405945A UA110280C2 UA 110280 C2 UA110280 C2 UA 110280C2 UA A201405945 A UAA201405945 A UA A201405945A UA A201405945 A UAA201405945 A UA A201405945A UA 110280 C2 UA110280 C2 UA 110280C2
Authority
UA
Ukraine
Prior art keywords
delivery
micellar
anticancer drug
polyethyleneoa
cooh
Prior art date
Application number
UAA201405945A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Larysa Remivna Kunytska
Tetiana Borysivna Zheltonozhska
Rostyslav Stepanovych Stoika
Natalia Mykolaivna Boiko
Original Assignee
Taras Shevchenko Kyiv Nat University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taras Shevchenko Kyiv Nat University filed Critical Taras Shevchenko Kyiv Nat University
Priority to UAA201405945A priority Critical patent/UA110280C2/en
Publication of UA110280C2 publication Critical patent/UA110280C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Винахід стосується міцелярної композиції для доставки протиракового препарату, що як міцелярні носії протиракового препарату містить частково гідролізовані подвійні гідрофільні диблок- або триблок-кополімери (ДБК-СООН або ТБК-СООН) поліакриламіду та метоксиполіетиленоксиду або поліетиленоксиду (МОПЕО--ПАА або ПАА--ПЕО--ПАА) з хімічно комплементарними блоками різної довжини, які утворюють інтрамолекулярні полікомплекси та міцелярні структури моно- і полімолекулярного типів, а як протираковий препарат містить гідрохлорид доксорубіцину.The invention relates to a micellar composition for the delivery of an anticancer drug, which as a micellar carrier of the anticancer drug contains partially hydrolyzed double hydrophilic diblock or triblock copolymers (DBK-COOH or TBK-COOH) polyacrylamide and methoxypolyethyleneOA or polyethyleneOA or polyethyleneOA - PAA) with chemically complementary blocks of different lengths, forming intramolecular polycomplexes and micellar structures of mono- and polymolecular types, and containing doxorubicin hydrochloride as an anticancer drug in.

UAA201405945A 2014-05-30 2014-05-30 Micellar composition for delivery of cancer drugs UA110280C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201405945A UA110280C2 (en) 2014-05-30 2014-05-30 Micellar composition for delivery of cancer drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201405945A UA110280C2 (en) 2014-05-30 2014-05-30 Micellar composition for delivery of cancer drugs

Publications (1)

Publication Number Publication Date
UA110280C2 true UA110280C2 (en) 2015-12-10

Family

ID=55171491

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201405945A UA110280C2 (en) 2014-05-30 2014-05-30 Micellar composition for delivery of cancer drugs

Country Status (1)

Country Link
UA (1) UA110280C2 (en)

Similar Documents

Publication Publication Date Title
CY1123953T1 (en) DELAYED RELEASE COMPOSITIONS OF LINACLOTIDE
EA201790024A1 (en) MODULATORS OF TOLL-LIKE RECEPTORS FOR HIV TREATMENT
EP3315608A4 (en) Sirna, pharmaceutical composition and conjugate which contain sirna, and uses thereof
DK3283521T3 (en) DRUG CONJUGATES INCLUDING ANTIBODIES TO CLAUDIN 18.2
MA41265A (en) COMPOSITIONS FOR THE ADMINISTRATION OF ILÉO-JEJUNAL DRUGS.
EP3302265A4 (en) Drug delivery capsule
AU2013225533A8 (en) Amido spirocyclic amide and sulfonamide derivatives
WO2014153030A3 (en) Methods of treating cancer and preventing cancer drug resistance
CY1121999T1 (en) PHARMACEUTICAL FORMS OF DARUNAVIR COMBINATION
EA201791454A1 (en) DRUG FORMS FOR TRANSDERMAL ADMINISTRATION
WO2014144295A8 (en) Ceftolozane antibiotic compositions
TR201821116A2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING POSACONAZOL AND THE MANUFACTURING METHOD
CY1119446T1 (en) PHARMACEUTICAL FORMS DARUNAVIRIS
CY1120098T1 (en) COMPOSITIONS CONTAINING BORTIOXETINE AND GONES
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
BR112016014880A2 (en) PHARMACEUTICAL COMPOSITION INCLUDING PALONOSETRON
EA201791600A1 (en) DERIVATIVES OF HYDROXIALKILPIPERASINE AS RECESSOR CXCR3 MODULATORS
MX2017012596A (en) A pharmaceutical composition and the use thereof.
TR201901977T4 (en) (R) -2-methyl-piperazine derivatives as Cxcr3 receptor modulators.
EA201991287A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS BASED ON TIKAGRELOR FOR ORAL USE
AU2015303724B2 (en) Quinazoline derivative
EP3453390A4 (en) Polymerized drug-containing pharmaceutical composition
EP3326628A4 (en) Pharmaceutical composition for oral administration comprising high concentration taxane
CY1120192T1 (en) UNIONS TO ENHANCE KNOWLEDGE FUNCTIONING